BioSpace News Archive

Drug Development

Pfizer Starts Global Phase 2/3 EPIC-PEP Study of Novel COVID-19 Oral Antiviral Candidate for Post-Exposure Prophylaxis in Adults

Pfizer Inc. announced the start of the Phase 2/3 EPIC-PEP study to evaluate the investigational novel oral antiviral candidate PF-07321332, co-administered with a low dose of ritonavir, for the prevention of COVID-19 infection.

September 27, 2021
·
8 min read
Pharm Country

Merck Announces KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Overall Survival (OS) in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib

Merck, known as MSD outside the United States and Canada, announced that the Phase 3 KEYNOTE-394 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in Asian patients with advanced hepatocellular carcinoma previously treated with sorafenib met its primary endpoint of overall survival.

September 27, 2021
·
40 min read
Business

Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2022 on November 9

Cardinal Health plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange.

September 27, 2021
·
1 min read
Angle PLC Announces Parsortix Demonstrates Ability to Isolate CTCs

ANGLE plc, a world-leading liquid biopsy company, is pleased to announce that the Molecular Oncology Group at the Medical University of Vienna, presented results of three studies at the 5th Advances in Circulating Tumour Cells conference, held 22-25 September in Kalamata, Greece.

September 27, 2021
·
9 min read
Seborrheic Keratosis Treatment Market to Witness Comprehensive Growth by 2026

The global seborrheic keratosis treatment market is expected to grow at a massive rate. With growing count of factors that support the cosmetic and aesthetic quotient, the market could attain a strong boost in future years.

September 27, 2021
·
6 min read
Protein Drugs Market: Manufacturers in the market are adopting the artificial intelligence (AI) technology to accelerate pharmaceutical development

Researchers are shifting focus on nonstructural protein 1, also called the SARS-CoV-2 protein, which is found to interact with the intracellular protein production to suppress the translation of mRNA into protein.

September 27, 2021
·
5 min read
Pneumatic Nebulizers Market | Rising Number of Occurrences of Respiratory Illnesses Drive the Market

The global Pneumatic Nebulizers market is projected to be driven by various factors such as rising incidences of chronic respiratory disease, an ageing population, and the need for home healthcare equipment.

September 27, 2021
·
4 min read
Neomycin Sulfate Market: The cream segment accounted for prominent share of the global market

Neomycin sulfate is a medication used to reduce the risk of infection after certain intestinal surgeries. Neomycin belongs to a class of drugs known as aminoglycoside antibiotics. It works by stopping the growth of bacteria in the intestines.

September 27, 2021
·
5 min read
Medical Simulation Market | Exclusive Report on Latest Trends and Future Scope in the Industry

The increasing use of advanced methods and approaches to provide medical education is projected to aid in the expansion of the global healthcare or medical simulation market.

September 27, 2021
·
4 min read
Medical Loupes Market | Asia Pacific Market is Projected to Develop at the Rapid Pace

Traditionally, the healthcare business has been heavily regulated and has been unwilling to embrace new technology readily.

September 27, 2021
·
4 min read